Brisbane-based respiratory health company ResApp (ASX:RAP) has launched an Android version of its sleep apnoea-detecting smartphone app, SleepCheck.

The company’s SleepCheck app is now available for Samsung Galaxy S9, S9+, S10, S10+ and S20 phones in 36 countries, ResApp said on Tuesday, with support for more devices anticipated in the near term.

For iPhone users, the app has been available in Apple’s App Store since April, where it retails for $7.99 and is listed as the sixth most popular medical app.

While there are free apps that record users’ snoring, ResApp says its app is more sophisticated, able to assess a user’s risk for sleep apnoea by analysing the sounds of their breathing and snoring patterns after recording them overnight.

ResApp says that a 238-patient clinical study has shown the app is as accurate as a full at-home sleep study, and the app has achieved CE Mark status in Europe and has been approved for listing as a class 1 medical device in Australia.

“SleepCheck is a very unique offering with broad reach and availability and it has considerable potential in the sleep health space,” says ResApp chief executive and managing director Dr Tony Keating.

“We are excited about the ongoing opportunities it will present for ResApp.”

The company plans a marketing campaign in Australia and the UK to drive product awareness, he added.

Shortly after the open, ResApp shares were up 1.3 per cent to 8.1c.